Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)

The summary for the Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed): The overall goal of the Stimulating Access to Research in Residency (StARR) program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical and research experience necessary to perform basic, clinical and/or translational research.
Federal Grant Title: Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-26-012
Type of Funding: Grant
CFDA Numbers: 93.837, 93.855, 93.866, 93.867
CFDA Descriptions: Information not provided
Current Application Deadline: January 10th, 2028
Original Application Deadline: January 10th, 2028
Posted Date: August 26th, 2025
Creation Date: August 26th, 2025
Archive Date: February 15th, 2028
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: August 26th, 2025
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-012.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
• Single Source: HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for P...
• HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Cli...
• Single Source: Bench to Bassinet Congenital Heart disease Advancing New understanding in G...
• Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Ad...
• Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Ad...
• The Relationship Between Hypertension and Inflammation
• Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
• Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health
• HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Tri...
• HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required)
• HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)
• HIV/AIDS Clinical Trials Network Leadership and Operations Centers (UM1 Clinical Trial Req...
• Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com